Trademarkia Logo

Canada

C$
RheumaTrace
SEARCHED

on 20 Mar 2025

Last Applicant/ Owned by

Nordic Bioscience A/S

Herlev Hovedgade 205DK-2730 Herlev

DK

Serial Number

2318064 filed on 19th Sept 2023

RheumaTrace

Trademark usage description

design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomar Read More

Classification Information


Class [005]
Pharmaceuticals and herbicides


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; development of diagnostic preparations, equipment and tests; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical development for medical and pharmaceutical research services; advice, information and assistance relating to the foregoing.


Classification kind code

12

Mark Details


Serial Number

2318064

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 20th Mar 2025
Search Recorded
Submitted for opposition 20
on 20th Mar 2025
Examiner's First Report
Submitted for opposition 223
on 20th Mar 2025
Total Provisional Refusal
Submitted for opposition 236
on 9th Feb 2025
Partial Withdrawal - Madrid Protocol
Submitted for opposition 256
on 28th Jan 2025
Notification of Possible Opposition Sent
Submitted for opposition 257
on 28th Mar 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 27th Mar 2024
Created
Submitted for opposition 31
on 27th Mar 2024
Formalized
Submitted for opposition 30
on 19th Sept 2023
Filed
Submitted for opposition 228
on 19th Sept 2023
International Registration